{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:40:33Z","timestamp":1786995633368,"version":"build-2736575974"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.phrs.2026.108139","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:46:24Z","timestamp":1771001184000},"page":"108139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Targeting Acod1\/itaconate in cancer therapy: Mechanisms and opportunities"],"prefix":"10.1016","volume":"225","author":[{"given":"Tianlin","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuodong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1031-5319","authenticated-orcid":false,"given":"Xiaodong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.phrs.2026.108139_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.43198","article-title":"Global disparities of cancer and its projected burden in 2050","volume":"7","author":"Bizuayehu","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"7","key":"10.1016\/j.phrs.2026.108139_bib2","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","article-title":"Embracing cancer complexity: Hallmarks of systemic disease","volume":"187","author":"Swanton","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.phrs.2026.108139_bib3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2026.108139_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-immunol-101220-031513","article-title":"Systems immunology approaches to metabolism","volume":"41","author":"Mogilenko","year":"2023","journal-title":"Annu Rev. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108139_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41574-022-00773-5","article-title":"Metabolic determinants of tumour initiation","volume":"19","author":"Brunner","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phrs.2026.108139_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216837","article-title":"The emerging role of lactate in tumor microenvironment and its clinical relevance","volume":"590","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"issue":"19","key":"10.1016\/j.phrs.2026.108139_bib7","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1073\/pnas.1218599110","article-title":"Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production","volume":"110","author":"Michelucci","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","article-title":"Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation","volume":"24","author":"Lampropoulou","year":"2016","journal-title":"Cell Metab."},{"issue":"7699","key":"10.1016\/j.phrs.2026.108139_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature25986","article-title":"Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1","volume":"556","author":"Mills","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108139_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5180242","article-title":"4-Octyl Itaconate prevents free fatty acid-induced lipid metabolism disorder through activating Nrf2-AMPK signaling pathway in hepatocytes","volume":"2022","author":"Chu","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"issue":"3","key":"10.1016\/j.phrs.2026.108139_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173034","article-title":"Itaconate suppresses atherosclerosis by activating a Nrf2-dependent antiinflammatory response in macrophages in mice","volume":"134","author":"Song","year":"2023","journal-title":"J. Clin. Invest"},{"issue":"12","key":"10.1016\/j.phrs.2026.108139_bib12","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.ccell.2024.10.010","article-title":"Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance","volume":"42","author":"Lin","year":"2024","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.phrs.2026.108139_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg0654","article-title":"Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy","volume":"9","author":"Chen","year":"2023","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib14","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1038\/s41467-023-43988-4","article-title":"Itaconate promotes hepatocellular carcinoma progression by epigenetic induction of CD8(+) T-cell exhaustion","volume":"14","author":"Gu","year":"2023","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.phrs.2026.108139_bib15","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1158\/0008-5472.CAN-24-2982","article-title":"Macrophage-derived itaconate suppresses dendritic cell function to promote acquired resistance to Anti-PD-1 immunotherapy","volume":"85","author":"Yang","year":"2025","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.phrs.2026.108139_bib16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41589-019-0323-5","article-title":"S-glycosylation-based cysteine profiling reveals regulation of glycolysis by itaconate","volume":"15","author":"Qin","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108139_bib17","first-page":"1067","article-title":"IRG1\/Itaconate induces metabolic reprogramming to suppress ER-positive breast cancer cell growth","volume":"13","author":"Wang","year":"2023","journal-title":"Am. J. Cancer Res"},{"issue":"9","key":"10.1016\/j.phrs.2026.108139_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110725","article-title":"Targeting ALDOA to modulate tumorigenesis and energy metabolism in retinoblastoma","volume":"27","author":"Wang","year":"2024","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jlac.18360190107","article-title":"Ueber eine neue Pyrogen-Citronens\u00e4ure, und \u00fcber Benennung der Pyrogen-S\u00e4uren \u00fcberhaupt","volume":"19","author":"Baup","year":"1836","journal-title":"Ann. der Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jlac.18400340104","article-title":"Untersuchungen \u00fcber das Verhalten der Citrons\u00e4ure in h\u00f6herer Temperatur und die daraus hervorgehenden Produkte","volume":"34","author":"Crasso","year":"1840","journal-title":"Justus Liebigs Ann. der Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib21","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1038\/s41467-022-33033-1","article-title":"Kinetic compartmentalization by unnatural reaction for itaconate production","volume":"13","author":"Ye","year":"2022","journal-title":"Nat. Commun."},{"issue":"32","key":"10.1016\/j.phrs.2026.108139_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn0414","article-title":"Reprogramming Yarrowia lipolytica metabolism for efficient synthesis of itaconic acid from flask to semipilot scale","volume":"10","author":"Fu","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1128\/jb.131.1.136-144.1977","article-title":"Itaconate, an isocitrate lyase-directed inhibitor in Pseudomonas indigofera","volume":"131","author":"McFadden","year":"1977","journal-title":"J. Bacteriol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1574-6968.2002.tb11413.x","article-title":"Inhibition of acetate and propionate assimilation by itaconate via propionyl-CoA carboxylase in isocitrate lyase-negative purple bacterium Rhodospirillum rubrum","volume":"216","author":"Berg","year":"2002","journal-title":"FEMS Microbiol. Lett."},{"issue":"5","key":"10.1016\/j.phrs.2026.108139_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nchembio.1482","article-title":"Bacterial itaconate degradation promotes pathogenicity","volume":"10","author":"Sasikaran","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"7702","key":"10.1016\/j.phrs.2026.108139_bib26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41586-018-0052-z","article-title":"Electrophilic properties of itaconate and derivatives regulate the I\u03baB\u03b6\u2013ATF3 inflammatory axis","volume":"556","author":"Bambouskova","year":"2018","journal-title":"NATURE"},{"issue":"9","key":"10.1016\/j.phrs.2026.108139_bib27","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1172\/JCI99169","article-title":"Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors","volume":"128","author":"Weiss","year":"2018","journal-title":"J. Clin. Invest"},{"issue":"12","key":"10.1016\/j.phrs.2026.108139_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1508","article-title":"Microbiota: a key factor affecting and regulating the efficacy of immunotherapy","volume":"13","author":"Jiang","year":"2023","journal-title":"Clin. Transl. Med"},{"issue":"7960","key":"10.1016\/j.phrs.2026.108139_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41586-023-06026-3","article-title":"Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance","volume":"617","author":"Park","year":"2023","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2026.108139_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41419-024-06483-2","article-title":"ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota","volume":"15","author":"Eberhart","year":"2024","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.phrs.2026.108139_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00018-023-04971-w","article-title":"Itaconate inhibits SYK through alkylation and suppresses inflammation against hvKP induced intestinal dysbiosis","volume":"80","author":"Li","year":"2023","journal-title":"Cell Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.phrs.2026.108139_bib32","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1038\/s41564-024-01862-z","article-title":"Enteric bacterial infection stimulates remodelling of bile metabolites to promote intestinal homeostasis","volume":"9","author":"Zhang","year":"2024","journal-title":"Nat. Microbiol."},{"issue":"10","key":"10.1016\/j.phrs.2026.108139_bib33","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1039\/C6GC00605A","article-title":"Itaconic acid\u2013a versatile building block for renewable polyesters with enhanced functionality","volume":"18","author":"Robert","year":"2016","journal-title":"Green Chem."},{"issue":"2","key":"10.1016\/j.phrs.2026.108139_bib34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/imcb.12218","article-title":"Itaconate: an emerging determinant of inflammation in activated macrophages","volume":"97","author":"Yu","year":"2019","journal-title":"Immunol. CELL Biol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108139_bib35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.it.2019.05.007","article-title":"The immunomodulatory potential of the metabolite itaconate","volume":"40","author":"Hooftman","year":"2019","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108139_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120254","article-title":"Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro","volume":"10","author":"Brennan","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.phrs.2026.108139_bib37","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1074\/jbc.C117.775270","article-title":"Dimethyl itaconate is not metabolized into itaconate intracellularly","volume":"292","author":"ElAzzouny","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"7702","key":"10.1016\/j.phrs.2026.108139_bib38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41586-018-0052-z","article-title":"Electrophilic properties of itaconate and derivatives regulate the I\u03baB\u03b6-ATF3 inflammatory axis","volume":"556","author":"Bambouskova","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108139_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156152","article-title":"Preclinical insights into the potential of itaconate and its derivatives for liver disease therapy","volume":"165","author":"Wu","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.phrs.2026.108139_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108906","article-title":"Macrophages at the crossroads of cellular senescence and cancer development and progression: therapeutic opportunities and challenges","author":"Jiang","year":"2025","journal-title":"Pharm. Ther."},{"issue":"15","key":"10.1016\/j.phrs.2026.108139_bib41","doi-asserted-by":"crossref","first-page":"7378","DOI":"10.7150\/thno.113727","article-title":"Focusing on the interplay between tumor-associated macrophages and tumor microenvironment: from mechanism to intervention","volume":"15","author":"Wu","year":"2025","journal-title":"Theranostics"},{"issue":"6282","key":"10.1016\/j.phrs.2026.108139_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.phrs.2026.108139_bib43","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.phrs.2026.108139_bib44","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","article-title":"Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.108139_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103711","article-title":"Radiation-induced upregulation of itaconate in macrophages promotes the radioresistance of non-small cell lung cancer by stabilizing NRF2 protein and suppressing immune response","volume":"85","author":"Che","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2026.108139_bib46","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","article-title":"From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation","volume":"5","author":"Italiani","year":"2014","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108139_bib47","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cmet.2020.07.016","article-title":"The immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation","volume":"32","author":"Hooftman","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2026.108139_bib48","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.54877","article-title":"Endogenous itaconate is not required for particulate matter-induced NRF2 expression or inflammatory response","volume":"9","author":"Sun","year":"2020","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.phrs.2026.108139_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108756","article-title":"Itaconate confers tolerance to late NLRP3 inflammasome activation","volume":"34","author":"Bambouskova","year":"2021","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.phrs.2026.108139_bib50","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1038\/s42255-022-00676-9","article-title":"Myeloid-derived itaconate suppresses cytotoxic CD8(+) T cells and promotes tumour growth","volume":"4","author":"Zhao","year":"2022","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib51","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1038\/s41467-023-41470-9","article-title":"Metabolic reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.phrs.2026.108139_bib52","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cmet.2022.02.002","article-title":"Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages","volume":"34","author":"Runtsch","year":"2022","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.phrs.2026.108139_bib53","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.immuni.2021.09.010","article-title":"IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation","volume":"54","author":"Faas","year":"2021","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.phrs.2026.108139_bib54","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41590-022-01181-7","article-title":"Itaconate modifies JAK1","volume":"23","author":"Bernard","year":"2022","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108139_bib55","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/cas.16068","article-title":"IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18\/STAT3 pathway","volume":"115","author":"Zhou","year":"2024","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.phrs.2026.108139_bib56","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cmet.2023.12.015","article-title":"ABCG2 is an itaconate exporter that limits antibacterial innate immunity by alleviating TFEB-dependent lysosomal biogenesis","volume":"36","author":"Chen","year":"2024","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.phrs.2026.108139_bib57","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cmet.2024.11.012","article-title":"Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1","volume":"37","author":"Fan","year":"2025","journal-title":"Cell Metab."},{"issue":"16","key":"10.1016\/j.phrs.2026.108139_bib58","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.1128\/JVI.00563-16","article-title":"Suppression of IRG-1 reduces inflammatory cell infiltration and lung injury in respiratory syncytial virus infection by reducing production of reactive oxygen species","volume":"90","author":"Ren","year":"2016","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108139_bib59","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1210\/en.2003-0585","article-title":"Immune-responsive gene 1 is a novel target of progesterone receptor and plays a critical role during implantation in the mouse","volume":"144","author":"Cheon","year":"2003","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.phrs.2026.108139_bib60","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.31147","article-title":"Immune-responsive gene 1\/itaconate activates nuclear factor erythroid 2-related factor 2 in hepatocytes to protect against liver ischemia-reperfusion injury","volume":"72","author":"Yi","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.phrs.2026.108139_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113984","article-title":"Acod1 expression in cancer cells promotes immune evasion through the generation of inhibitory peptides","volume":"43","author":"Schofield","year":"2024","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.phrs.2026.108139_bib62","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3892\/or.2014.3474","article-title":"Immune responsive gene 1, a novel oncogene, increases the growth and tumorigenicity of glioma","volume":"32","author":"Pan","year":"2014","journal-title":"Oncol. Rep."},{"issue":"22","key":"10.1016\/j.phrs.2026.108139_bib63","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1038\/s44318-024-00217-y","article-title":"Cancer cell-intrinsic biosynthesis of itaconate promotes tumor immunogenicity","volume":"43","author":"Wang","year":"2024","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.phrs.2026.108139_bib64","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/2159-8290.CD-20-1211","article-title":"Metabolic codependencies in the tumor microenvironment","volume":"11","author":"Dey","year":"2021","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.phrs.2026.108139_bib65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: Still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.phrs.2026.108139_bib66","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+ T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat. Rev. IMMUNOLOGY"},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib67","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-immunol-082223-044122","article-title":"Molecular mechanisms governing CD8 T cell differentiation and checkpoint inhibitor response in cancer","volume":"43","author":"Rausch","year":"2025","journal-title":"Annu Rev. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib68","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/s12951-025-03507-7","article-title":"Reprogramming tumor-associated macrophages and blocking PD-L1 via engineered outer membrane vesicles to enhance T cell infiltration and cytotoxic functions","volume":"23","author":"Chen","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phrs.2026.108139_bib69","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu Rev. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108139_bib70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41577-018-0088-1","article-title":"Dendritic cell subsets in T cell programming: location dictates function","volume":"19","author":"Eisenbarth","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108139_bib72","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell Mol. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108139_bib73","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41385-021-00462-y","article-title":"Irg1\/itaconate metabolic pathway is a crucial determinant of dendritic cells immune-priming function and contributes to resolute allergen-induced airway inflammation","volume":"15","author":"Jaiswal","year":"2022","journal-title":"Mucosal Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108139_bib74","article-title":"Itaconate attenuates autoimmune hepatitis via PI3K\/AKT\/mTOR pathway-mediated inhibition of dendritic cell maturation and autophagy","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.phrs.2026.108139_bib75","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.2147\/JIR.S516085","article-title":"4-Octyl itaconate modulates dendritic cells function and tumor immunity via NRF2 activation","volume":"18","author":"Zhu","year":"2025","journal-title":"J. Inflamm. Res."},{"issue":"8","key":"10.1016\/j.phrs.2026.108139_bib76","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat. Med."},{"issue":"7939","key":"10.1016\/j.phrs.2026.108139_bib77","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","article-title":"Ferroptosis of tumour neutrophils causes immune suppression in cancer","volume":"612","author":"Kim","year":"2022","journal-title":"Nature"},{"issue":"7938","key":"10.1016\/j.phrs.2026.108139_bib78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","article-title":"Liver tumour immune microenvironment subtypes and neutrophil heterogeneity","volume":"612","author":"Xue","year":"2022","journal-title":"Nature"},{"issue":"7980","key":"10.1016\/j.phrs.2026.108139_bib79","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-023-06511-9","article-title":"CD300ld on neutrophils is required for tumour-driven immune suppression","volume":"621","author":"Wang","year":"2023","journal-title":"Nature"},{"issue":"6679","key":"10.1016\/j.phrs.2026.108139_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf6493","article-title":"Deterministic reprogramming of neutrophils within tumors","volume":"383","author":"Ng","year":"2024","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.phrs.2026.108139_bib81","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.cmet.2023.09.004","article-title":"Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1","volume":"35","author":"Zhao","year":"2023","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.phrs.2026.108139_bib82","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.chom.2023.10.015","article-title":"Trained immunity: target for prophylaxis and therapy","volume":"31","author":"Ziogas","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.phrs.2026.108139_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.827407","article-title":"Immune tolerance vs. immune resistance: the interaction between host and pathogens in infectious diseases","volume":"9","author":"Ahmad","year":"2022","journal-title":"Front Vet. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu0292","article-title":"Systemically inducing trained immunity overcomes solid tumors' immunosuppressive microenvironment","volume":"12","author":"Priem","year":"2026","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib85","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmet.2018.09.003","article-title":"The itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity","volume":"29","author":"Dom\u00ednguez-Andr\u00e9s","year":"2019","journal-title":"Cell Metab."},{"issue":"27","key":"10.1016\/j.phrs.2026.108139_bib86","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.phrs.2026.108139_bib87","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMc2210546","article-title":"Durability of booster mRNA vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 subvariants","volume":"387","author":"Qu","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.phrs.2026.108139_bib88","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.7150\/thno.110305","article-title":"Boosting mRNA cancer vaccine efficacy via targeting Irg1 on macrophages in lymph nodes","volume":"15","author":"Wei","year":"2025","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.phrs.2026.108139_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112658","article-title":"Dimethyl itaconate induces long-term innate immune responses and confers protection against infection","volume":"42","author":"Ferreira","year":"2023","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib90","first-page":"65","article-title":"Radiotherapy combination opportunities leveraging immunity for the next oncology practice","volume":"67","author":"Herrera","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phrs.2026.108139_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.106212","article-title":"Low dose ionizing radiation effects on the immune system","volume":"149","author":"Lumniczky","year":"2021","journal-title":"Environ. Int."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib92","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","article-title":"Molecular mechanisms of tumor resistance to radiotherapy","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"8072","key":"10.1016\/j.phrs.2026.108139_bib93","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41586-025-08994-0","article-title":"Radiation-induced amphiregulin drives tumour metastasis","volume":"643","author":"Piffk\u00f3","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib94","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","article-title":"Advances in cancer immunotherapy: historical perspectives, current developments, and future directions","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.phrs.2026.108139_bib95","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.phrs.2026.108139_bib96","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib97","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41420-024-02010-6","article-title":"Ubiquitin specific peptidase 3: an emerging deubiquitinase that regulates physiology and diseases","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib98","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"11","key":"10.1016\/j.phrs.2026.108139_bib99","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1158\/0008-5472.CAN-21-3013","article-title":"TET2 suppresses VHL deficiency-driven clear cell renal cell carcinoma by inhibiting HIF signaling","volume":"82","author":"Zhang","year":"2022","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.phrs.2026.108139_bib100","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.stem.2023.07.001","article-title":"TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal","volume":"30","author":"Li","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib101","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12964-024-01799-0","article-title":"Tumor-associated macrophage-derived itaconic acid contributes to nasopharyngeal carcinoma progression by promoting immune escape via TET2","volume":"22","author":"Zhang","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"3","key":"10.1016\/j.phrs.2026.108139_bib102","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ccell.2024.01.013","article-title":"Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment","volume":"42","author":"He","year":"2024","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.phrs.2026.108139_bib103","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.cell.2023.02.032","article-title":"A neutrophil response linked to tumor control in immunotherapy","volume":"186","author":"Gungabeesoon","year":"2023","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.phrs.2026.108139_bib104","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.cell.2023.03.007","article-title":"T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants","volume":"186","author":"Hirschhorn","year":"2023","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.phrs.2026.108139_bib105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccell.2023.12.005","article-title":"Interferon-stimulated neutrophils as a predictor of immunotherapy response","volume":"42","author":"Benguigui","year":"2024","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.phrs.2026.108139_bib106","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","article-title":"Neutrophil profiling illuminates anti-tumor antigen-presenting potency","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib107","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2026.108139_bib108","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib109","doi-asserted-by":"crossref","DOI":"10.1186\/s40170-016-0163-7","article-title":"Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration","volume":"5","author":"Balaban","year":"2017","journal-title":"Cancer Metab."},{"issue":"8","key":"10.1016\/j.phrs.2026.108139_bib110","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1172\/JCI127201","article-title":"Adipocyte and lipid metabolism in cancer drug resistance","volume":"129","author":"Cao","year":"2019","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib111","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s12964-024-01760-1","article-title":"The significant role of amino acid metabolic reprogramming in cancer","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"8","key":"10.1016\/j.phrs.2026.108139_bib112","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.tem.2018.05.003","article-title":"Roles of aldolase family genes in human cancers and diseases","volume":"29","author":"Chang","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.phrs.2026.108139_bib113","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1111\/jcmm.13732","article-title":"Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer","volume":"22","author":"Jiang","year":"2018","journal-title":"J. Cell Mol. Med"},{"issue":"2","key":"10.1016\/j.phrs.2026.108139_bib114","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbrc.2018.02.123","article-title":"Aldolase A overexpression is associated with poor prognosis and promotes tumor progression by the epithelial-mesenchymal transition in colon cancer","volume":"497","author":"Ye","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"issue":"11","key":"10.1016\/j.phrs.2026.108139_bib115","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1007\/s10620-019-05642-2","article-title":"Fructose-bisphosphate Aldolase A regulates hypoxic adaptation in hepatocellular carcinoma and involved with tumor malignancy","volume":"64","author":"Li","year":"2019","journal-title":"Dig. Dis. Sci."},{"issue":"8","key":"10.1016\/j.phrs.2026.108139_bib116","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1111\/cas.14524","article-title":"Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma","volume":"111","author":"Saito","year":"2020","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.phrs.2026.108139_bib117","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3390\/biom10101429","article-title":"Role of glutathione in cancer: from mechanisms to therapies","volume":"10","author":"Kennedy","year":"2020","journal-title":"Biomolecules"},{"issue":"10-12","key":"10.1016\/j.phrs.2026.108139_bib118","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/ars.2024.0629","article-title":"4-Octyl itaconate attenuates cell proliferation by cellular senescence via glutathione metabolism disorders and mitochondrial dysfunction in melanoma","volume":"42","author":"Hayashi","year":"2025","journal-title":"Antioxid. Redox Signal"},{"issue":"7","key":"10.1016\/j.phrs.2026.108139_bib119","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/gtc.12499","article-title":"Identification of ACA-28, a 1\u2032-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cells","volume":"22","author":"Satoh","year":"2017","journal-title":"Genes Cells"},{"issue":"10","key":"10.1016\/j.phrs.2026.108139_bib120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","article-title":"ERK signalling: a master regulator of cell behaviour, life and fate","volume":"21","author":"Lavoie","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib121","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41698-024-00554-5","article-title":"ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework","volume":"8","author":"Timofeev","year":"2024","journal-title":"NPJ Precis Oncol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108139_bib122","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.62347\/LHYO6433","article-title":"Itaconate targets the ERK2 signal to suppress estrogen receptor-positive breast cancer cell growth","volume":"15","author":"Wang","year":"2025","journal-title":"Am. J. Cancer Res"},{"issue":"6","key":"10.1016\/j.phrs.2026.108139_bib123","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00280-011-1654-4","article-title":"Nitric oxide: role in tumour biology and iNOS\/NO-based anticancer therapies","volume":"67","author":"Singh","year":"2011","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.phrs.2026.108139_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216931","article-title":"Unveiling the significance of inducible nitric oxide synthase: its impact on cancer progression and clinical implications","volume":"592","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"issue":"5-6","key":"10.1016\/j.phrs.2026.108139_bib125","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.cr.7290133","article-title":"The role of nitric oxide in cancer","volume":"12","author":"Xu","year":"2002","journal-title":"Cell Res."},{"key":"10.1016\/j.phrs.2026.108139_bib126","article-title":"Preclinical evaluation of dimethyl itaconate against hepatocellular carcinoma via activation of the e\/iNOS-mediated NF-\u03baB-dependent apoptotic pathway","volume":"12","author":"Gautam","year":"2021","journal-title":"Front. Pharm."},{"key":"10.1016\/j.phrs.2026.108139_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119847","article-title":"Antitumor effect of dimethyl itaconate on thymic carcinoma by targeting LDHA-mTOR axis","volume":"282","author":"Hayashi","year":"2021","journal-title":"Life Sci."},{"issue":"5497","key":"10.1016\/j.phrs.2026.108139_bib128","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","article-title":"Autophagy as a regulated pathway of cellular degradation","volume":"290","author":"Klionsky","year":"2000","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.phrs.2026.108139_bib129","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.215152","article-title":"Autophagy-dependent cell death - where, how and why a cell eats itself to death","volume":"131","author":"Bialik","year":"2018","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.phrs.2026.108139_bib130","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41419-022-04974-8","article-title":"Induction of autophagy-dependent ferroptosis to eliminate drug-tolerant human retinoblastoma cells","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.phrs.2026.108139_bib131","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1039\/D5CS00083A","article-title":"Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond","volume":"54","author":"Mao","year":"2025","journal-title":"Chem. Soc. Rev."},{"issue":"11","key":"10.1016\/j.phrs.2026.108139_bib132","article-title":"Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma","volume":"4","author":"Xing","year":"2023","journal-title":"Cell Rep. Med"},{"issue":"4","key":"10.1016\/j.phrs.2026.108139_bib133","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41418-023-01125-0","article-title":"Cuproptosis: p53-regulated metabolic cell death","volume":"30","author":"Xiong","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.phrs.2026.108139_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114301","article-title":"4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer","volume":"159","author":"Yang","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2026.108139_bib135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N. Engl. J. Med"},{"issue":"21","key":"10.1016\/j.phrs.2026.108139_bib136","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib137","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","article-title":"Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways","volume":"19","author":"Kraehenbuehl","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6230","key":"10.1016\/j.phrs.2026.108139_bib138","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.phrs.2026.108139_bib139","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1470-2045(17)30516-8","article-title":"Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis","volume":"18","author":"Turajlic","year":"2017","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108139_bib140","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.phrs.2026.108139_bib141","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1172\/JCI127471","article-title":"cGAS\/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity","volume":"129","author":"Wang","year":"2019","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.phrs.2026.108139_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107376","article-title":"STING-IRG1 inhibits liver metastasis of colorectal cancer by regulating the polarization of tumor-associated macrophages","volume":"26","author":"Liu","year":"2023","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.phrs.2026.108139_bib143","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3892\/ijo.2014.2794","article-title":"CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma","volume":"46","author":"Meng","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108139_bib144","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003973","article-title":"Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer","volume":"9","author":"Long","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phrs.2026.108139_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omto.2022.03.004","article-title":"CCL18 promotes breast cancer progression by exosomal miR-760 activation of ARF6\/Src\/PI3K\/Akt pathway","volume":"25","author":"Huang","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.phrs.2026.108139_bib146","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbrc.2022.03.106","article-title":"OI inhibits development of ovarian cancer by blocking crosstalk between cancer cells and macrophages via HIF-1\u03b1 pathway","volume":"606","author":"Zhan","year":"2022","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2026.108139_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.703995","article-title":"Prognostic factors for overall survival in nasopharyngeal cancer and implication for TNM Staging by UICC: a systematic review of the literature","volume":"11","author":"Chiang","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.phrs.2026.108139_bib148","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000003753","article-title":"Update on the global, regional, and national burden of pancreatic cancer: insights from the Global Burden of Disease 2021 Study","author":"Cheng","year":"2025","journal-title":"Chin. Med J. (Engl. )"},{"issue":"5","key":"10.1016\/j.phrs.2026.108139_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188958","article-title":"Therapeutic advances targeting tumor angiogenesis in pancreatic cancer: current dilemmas and future directions","volume":"1878","author":"An","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"5-6","key":"10.1016\/j.phrs.2026.108139_bib150","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10495-023-01823-7","article-title":"Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making","volume":"28","author":"Zhu","year":"2023","journal-title":"Apoptosis"},{"issue":"6","key":"10.1016\/j.phrs.2026.108139_bib151","first-page":"574","article-title":"Drug evaluation: STA-4783--enhancing taxane efficacy by induction of Hsp70","volume":"7","author":"Gehrmann","year":"2006","journal-title":"Curr. Opin. Invest. Drugs"},{"issue":"6","key":"10.1016\/j.phrs.2026.108139_bib152","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s40257-023-00795-3","article-title":"Global incidence, mortality, risk factors and trends of melanoma: a systematic analysis of registries","volume":"24","author":"Huang","year":"2023","journal-title":"Am. J. Clin. Dermatol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108139_bib153","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.phrs.2026.108139_bib154","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.936","article-title":"The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer","volume":"5","author":"Mazidimoradi","year":"2022","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108139_bib155","article-title":"The contemporary management of prostate cancer","author":"Chakrabarti","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"6548","key":"10.1016\/j.phrs.2026.108139_bib156","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/377446a0","article-title":"Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B","volume":"377","author":"Darmon","year":"1995","journal-title":"Nature"},{"issue":"7 3","key":"10.1016\/j.phrs.2026.108139_bib157","doi-asserted-by":"crossref","first-page":"S1749","DOI":"10.1097\/JTO.0b013e31821ea5f7","article-title":"Chemotherapy definitions and policies for thymic malignancies","volume":"6","author":"Girard","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.phrs.2026.108139_bib158","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lungcan.2018.10.018","article-title":"Systemic treatments for thymoma and thymic carcinoma: a systematic review","volume":"126","author":"Berghmans","year":"2018","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib159","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40164-025-00684-x","article-title":"Global burden and trends of hematologic malignancies based on Global Cancer Observatory 2022 and Global Burden of Disease 2021","volume":"14","author":"Pan","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.phrs.2026.108139_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103193","article-title":"Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: population-based estimates from GLOBOCAN 2022","volume":"83","author":"Sun","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib161","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2014.04.023","article-title":"Increased incidence and disparity of diagnosis of retinoblastoma patients in Guatemala","volume":"351","author":"Dean","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2026.108139_bib162","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/nrdp.2015.21","article-title":"Retinoblastoma","volume":"1","author":"Dimaras","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.phrs.2026.108139_bib163","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jnci\/53.2.347","article-title":"Characteristics of an established cell line of retinoblastoma","volume":"53","author":"Reid","year":"1974","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.phrs.2026.108139_bib164","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/procel\/pwaf012","article-title":"Targeting IRG1 in tumor-associated macrophages for cancer therapy","volume":"16","author":"Liu","year":"2025","journal-title":"Protein Cell"},{"key":"10.1016\/j.phrs.2026.108139_bib165","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jconrel.2020.04.031","article-title":"Bacterial outer membrane vesicles as a platform for biomedical applications: an update","volume":"323","author":"Li","year":"2020","journal-title":"J. Control Release"},{"issue":"2","key":"10.1016\/j.phrs.2026.108139_bib166","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/v8020045","article-title":"Big data offers novel insights for oncolytic virus immunotherapy","volume":"8","author":"Swift","year":"2016","journal-title":"Viruses"},{"issue":"20","key":"10.1016\/j.phrs.2026.108139_bib167","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.3390\/ijms21207505","article-title":"Clinical application of oncolytic viruses: a systematic review","volume":"21","author":"Cook","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2026.108139_bib168","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001486","article-title":"Clinical landscape of oncolytic virus research in 2020","volume":"8","author":"Macedo","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2026.108139_bib169","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/mt.2011.144","article-title":"Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus","volume":"19","author":"Liikanen","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2026.108139_bib170","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/srep02375","article-title":"Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy","volume":"3","author":"Liu","year":"2013","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib171","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1038\/s41467-024-48422-x","article-title":"Octyl itaconate enhances VSV\u039451 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways","volume":"15","author":"Kurmasheva","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.phrs.2026.108139_bib172","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s11746-014-2459-5","article-title":"2-Fatty acrylic acids: new highly derivatizable lipophilic platform molecules","volume":"91","author":"Zerkowski","year":"2014","journal-title":"J. Am. Oil Chem. ' Soc."},{"issue":"1","key":"10.1016\/j.phrs.2026.108139_bib173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11030-020-10147-6","article-title":"Itaconic acid hybrids as potential anticancer agents","volume":"26","author":"Perkovi\u0107","year":"2022","journal-title":"Mol. Divers"},{"issue":"8","key":"10.1016\/j.phrs.2026.108139_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114570","article-title":"Endogenously produced itaconate negatively regulates innate-driven cytokine production and drives global ubiquitination in human macrophages","volume":"43","author":"Bourner","year":"2024","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.phrs.2026.108139_bib175","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.cmet.2025.05.012","article-title":"Itaconate promotes inflammatory responses in tissue-resident alveolar macrophages and exacerbates acute lung injury","volume":"37","author":"Shan","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2026.108139_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115521","article-title":"Itaconate: a promising precursor for treatment of neuroinflammation associated depression","volume":"167","author":"Liu","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2026.108139_bib177","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41556-022-00853-8","article-title":"Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses","volume":"24","author":"Chen","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2026.108139_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1572985","article-title":"Itaconate and obesity-related hormones promote tumor progression - new insights on metabolic dysfunction in early-onset colon cancer","volume":"16","author":"Scheurlen","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108139_bib179","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202215931","article-title":"Macrophages inhibit Coxiella burnetii by the ACOD1-itaconate pathway for containment of Q fever","volume":"15","author":"Kohl","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2026.108139_bib180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1427457","article-title":"Divergent effects of itaconate isomers on Coxiella burnetii growth in macrophages and in axenic culture","volume":"15","author":"Siddique","year":"2024","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108139_bib181","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1661","article-title":"ACOD1, rather than itaconate, facilitates p62-mediated activation of Nrf2 in microglia post spinal cord contusion","volume":"14","author":"Qian","year":"2024","journal-title":"Clin. Transl. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182600054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182600054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T21:01:40Z","timestamp":1777323700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366182600054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":181,"alternative-id":["S104366182600054X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108139","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Acod1\/itaconate in cancer therapy: Mechanisms and opportunities","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108139"}}